{"id":"https://openalex.org/W1911942872","doi":null,"title":"Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis.","display_name":"Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis.","publication_year":2014,"publication_date":"2014-06-01","ids":{"openalex":"https://openalex.org/W1911942872","mag":"1911942872","pmid":"https://pubmed.ncbi.nlm.nih.gov/24922692"},"language":"en","primary_location":{"id":"pmid:24922692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24922692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://ar.iiarjournals.org/content/34/6/3185.full.pdf+html","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012176145","display_name":"Melissa Bersanelli","orcid":"https://orcid.org/0000-0002-6527-6281","observed_orcids":["https://orcid.org/0000-0002-6527-6281"]},"institutions":[{"id":"https://openalex.org/I124601658","display_name":"University of Parma","ror":"https://ror.org/02k7wn190","country_code":"IT","type":"education","lineage":["https://openalex.org/I124601658"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Melissa Bersanelli","raw_affiliation_strings":["Medical Oncology Unit, University Hospital of Parma, Parma, Italy melissa.bersanelli@alice.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy melissa.bersanelli@alice.it","institution_ids":["https://openalex.org/I124601658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071783009","display_name":"Marcello Tiseo","orcid":"https://orcid.org/0000-0002-9553-8465","observed_orcids":["https://orcid.org/0000-0002-9553-8465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcello Tiseo","raw_affiliation_strings":["Medical Oncology Unit, University Hospital of Parma, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015790566","display_name":"Fabrizio Artioli","orcid":"https://orcid.org/0000-0002-2607-6260","observed_orcids":["https://orcid.org/0000-0002-2607-6260"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabrizio Artioli","raw_affiliation_strings":["Medical Oncology Unit, Hospitals of Carpi and Mirandola, Modena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Hospitals of Carpi and Mirandola, Modena, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086650042","display_name":"Leonardo Lucchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109058","display_name":"Azienda Ospedaliero-Universitaria di Modena","ror":"https://ror.org/01hmmsr16","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109058"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Leonardo Lucchi","raw_affiliation_strings":["Nephrology and Dialysis Unit, University Hospital of Modena, Modena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology and Dialysis Unit, University Hospital of Modena, Modena, Italy","institution_ids":["https://openalex.org/I4210109058"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032386417","display_name":"Andrea Ardizzoni","orcid":"https://orcid.org/0000-0003-2678-0714","observed_orcids":["https://orcid.org/0000-0003-2678-0714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Ardizzoni","raw_affiliation_strings":["Medical Oncology Unit, University Hospital of Parma, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, University Hospital of Parma, Parma, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4227,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.8828327,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"34","issue":"6","first_page":"3185","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8610000014305115},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.703000009059906},{"id":"https://openalex.org/keywords/drug-safety-in-renal-failure","display_name":"drug safety in renal failure","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9280887842178345},{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.9180213212966919},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8847575783729553},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.659924328327179},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.62203049659729},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5894715189933777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5440118312835693},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5335626602172852},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5216634273529053},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5184028148651123},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49425840377807617},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.49267107248306274},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4904627501964569},{"id":"https://openalex.org/C2779563347","wikidata":"https://www.wikidata.org/wiki/Q843799","display_name":"Adenocarcinoma of the lung","level":4,"score":0.4657937288284302},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.43527668714523315},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.4181044399738312},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.41698768734931946},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.060314446687698364}],"mesh":[{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:24922692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24922692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Case Reports"},{"id":"pmh:oai:cris.unibo.it:11585/592112","doi":null,"is_oa":true,"landing_page_url":"http://ar.iiarjournals.org/content/34/6/3185.full.pdf+html","pdf_url":"http://ar.iiarjournals.org/content/34/6/3185.full.pdf+html","source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1911942872","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24922692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:cris.unibo.it:11585/592112","doi":null,"is_oa":true,"landing_page_url":"http://ar.iiarjournals.org/content/34/6/3185.full.pdf+html","pdf_url":"http://ar.iiarjournals.org/content/34/6/3185.full.pdf+html","source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1911942872.pdf","grobid_xml":"https://content.openalex.org/works/W1911942872.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W16169878","https://openalex.org/W31668175","https://openalex.org/W1984395308","https://openalex.org/W2004241567","https://openalex.org/W2007494957","https://openalex.org/W2021902787","https://openalex.org/W2033329878","https://openalex.org/W2042290667","https://openalex.org/W2077060090","https://openalex.org/W2096198395","https://openalex.org/W2115620060","https://openalex.org/W2132540363","https://openalex.org/W2152905269","https://openalex.org/W2160336497","https://openalex.org/W2168537144","https://openalex.org/W2171139285","https://openalex.org/W2171990964"],"related_works":["https://openalex.org/W2559181487","https://openalex.org/W2004241567","https://openalex.org/W2122410113","https://openalex.org/W4367604684","https://openalex.org/W4367605292","https://openalex.org/W4367602527","https://openalex.org/W7018151284","https://openalex.org/W2077060090","https://openalex.org/W4367602526","https://openalex.org/W4392005150"],"abstract_inverted_index":{"Renal":[0],"failure":[1],"in":[2,51,59,106],"cancer":[3,40],"patients":[4,41,60,108],"is":[5],"not":[6],"a":[7,36,66,75],"rare":[8],"clinical":[9],"condition":[10],"and":[11,87],"often":[12],"contraindicates":[13],"anticancer":[14],"drug":[15],"treatment;":[16],"moreover,":[17],"chemotherapeutic":[18],"drugs":[19],"are":[20],"frequently":[21],"identified":[22],"as":[23],"possible":[24],"iatrogenic":[25],"cause":[26],"of":[27,49,74],"renal":[28,44,111],"failure.":[29],"Molecular":[30],"therapies,":[31],"when":[32],"appropriate,":[33],"could":[34],"represent":[35],"therapeutic":[37],"option":[38],"for":[39],"with":[42,77,85,89,109],"severe":[43],"disease,":[45],"but":[46],"the":[47,71,94],"lack":[48],"knowledge":[50,70],"this":[52],"field,":[53],"at":[54,68],"present,":[55],"limits":[56],"their":[57],"use":[58],"undergoing":[61],"dialysis.":[62],"Herein":[63],"we":[64,91],"describe":[65],"case,":[67],"our":[69],"first":[72],"reported,":[73],"patient":[76],"advanced":[78],"lung":[79],"adenocarcinoma":[80],"on":[81,96],"maintenance":[82],"hemodialysis":[83],"treated":[84],"gefitinib":[86],"then":[88],"afatinib;":[90],"also":[92],"reviewed":[93],"literature":[95],"epidermal":[97],"growth":[98],"factor":[99],"receptor":[100],"(EGFR)":[101],"tyrosine-kinase":[102],"inhibitors":[103],"(TKIs)":[104],"used":[105],"NSCLC":[107],"concomitant":[110],"impairment.":[112]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}